JIR
The Journal of Inflammation Research is a peer-reviewed, open access medical journal dedicated to the rapid publication of research on all aspects of inflammation. With an ISSN of 1178-7031 and a 2026 Impact Factor of 4.6310, the journal occupies a solid position in the Q3 quartile of its field, serving as a respected platform for advancing knowledge in immunology and inflammatory disease mechanisms. Its scope encompasses a wide range of topics, including the molecular and cellular biology of inflammation, the pathophysiology of acute and chronic inflammatory conditions, the identification of novel biomarkers, and the development of anti-inflammatory therapeutics. The journal welcomes a variety of article types, including original research articles, comprehensive reviews, clinical studies, short reports, and methodology papers. Its target audience is diverse, comprising basic science researchers, clinical immunologists, rheumatologists, gastroenterologists, dermatologists, and other specialists investigating inflammatory processes across multiple organ systems. A key notable feature is its open access model, published by Dove Medical Press, which ensures that all articles are freely and permanently available online immediately upon publication, maximizing global readership and citation potential. The journal’s standing is reflected in its impact factor, which, while in the third quartile, indicates consistent and credible scholarly contribution within the competitive inflammation research landscape, making it a suitable venue for researchers seeking to disseminate findings to a specialized yet broad international audience.